Jackson Square Capital’s BeOne Medicines Ltd ONC Stock Holding History

Jackson Square Capital’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$518K	Buy	+1,415	New	+$484K	0.08%	106

Other funds holding ONC

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

TAA

TB Alternative Assets Grand Cayman, Cayman Islands $488M AUM 102.53% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

WESPAC Advisors SoCal Pasadena, California $553M AUM 26.96% 1-Year Est. Return

Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

Charles Schwab Trust Henderson, Nevada $1.73B AUM 11.35% 1-Year Est. Return

Tuttle Capital Management Riverside, Connecticut $230M AUM 58.79% 1-Year Est. Return

Jackson Square Capital's ONC Position: Q3 2026 in Review

Jackson Square Capital opened a new position in BeOne Medicines Ltd (ONC) in Q3 2026: 1,415 shares worth $518K. The stake represents 0.08% of the portfolio and ranks #106 among its holdings.

40 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

Jackson Square Capital held 1,415 shares of BeOne Medicines Ltd worth $518K as of Q3 2026.
BeOne Medicines Ltd was a new Jackson Square Capital position in Q3 2026.
BeOne Medicines Ltd made up 0.08% of Jackson Square Capital's portfolio in Q3 2026, its #106 holding.
40 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.